MARKET

BDSX

BDSX

BIODESIX INC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.21
-0.53
-5.44%
After Hours: 9.21 0 0.00% 16:00 08/03 EDT
OPEN
9.76
PREV CLOSE
9.74
HIGH
10.11
LOW
8.94
VOLUME
170.59K
TURNOVER
--
52 WEEK HIGH
31.99
52 WEEK LOW
8.85
MARKET CAP
243.34M
P/E (TTM)
-7.7259
1D
5D
1M
3M
1Y
5Y
Biodesix to Present at the Canaccord Genuity 41st Annual Growth Conference
BOULDER, Colo., August 02, 2021--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present at the Canaccord Genuity 41st A...
Business Wire · 1d ago
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28)
Benzinga · 5d ago
Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021
BOULDER, Colo., July 27, 2021--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial results for the second quarter ended June 30, 2021 after the close...
Business Wire · 07/27 10:00
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20)
Benzinga · 07/21 11:52
What Kind Of Shareholders Hold The Majority In Biodesix, Inc.'s (NASDAQ:BDSX) Shares?
Every investor in Biodesix, Inc. ( NASDAQ:BDSX ) should be aware of the most powerful shareholder groups. Insiders...
Simply Wall St. · 07/17 08:00
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7)
Benzinga · 07/08 11:45
Stocks That Hit 52-Week Lows On Tuesday
    Tuesday morning, 51 companies reached new 52-week lows.
Benzinga · 07/06 14:05
Is Biodesix, Inc. (BDSX) A Good Stock To Buy?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bou...
Insider Monkey · 06/23 19:07
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BDSX. Analyze the recent business situations of BIODESIX INC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BDSX stock price target is 27.33 with a high estimate of 31.00 and a low estimate of 23.00.
EPS
Institutional Holdings
Institutions: 48
Institutional Holdings: 4.25M
% Owned: 16.07%
Shares Outstanding: 26.42M
TypeInstitutionsShares
Increased
14
302.86K
New
8
690.81K
Decreased
16
272.15K
Sold Out
8
269.79K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.78%
Healthcare Providers & Services
+0.99%
Key Executives
Non-Executive Chairman/Independent Director
John Patience
President/Chief Executive Officer/Director
Scott Hutton
Chief Financial Officer/Treasurer/Secretary
Robin Cowie
Chief Accounting Officer
Ryan Siurek
Other
Kieran O'Kane
Independent Director
Jean Franchi
Independent Director
Hany Massarany
Independent Director
Jack Schuler
Independent Director
Matthew Strobeck
Independent Director
Charles Watts
No Data
About BDSX
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.

Webull offers kinds of Biodesix Inc stock information, including NASDAQ:BDSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDSX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BDSX stock methods without spending real money on the virtual paper trading platform.